EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Machine learning for synergistic network pharmacology: a comprehensive overview

Fatima Noor, Muhammad Asif, Usman Ali Ashfaq, Muhammad Qasim, Muhammad Tahir Ul Qamar

Briefings in Bioinformatics · 19.05.2023 · 24 (3)

DOI: 10.1093/bib/bbad120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 06.04.2023. Verfasst von Fatima Noor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan. Hauptthemen laut MEDLINE: Network Pharmacology, Pharmacology. Die Arbeit wurde bisher 217-mal zitiert (Crossref) und nennt 216 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Network pharmacology is an emerging area of systematic drug research that attempts to understand drug actions and interactions with multiple targets. Network pharmacology has changed the paradigm from ‘one-target one-drug’ to highly potent ‘multi-target drug’. Despite that, this synergistic approach is currently facing many challenges particularly mining effective information such as drug targets, mechanism of action, and drug and organism interaction from massive, heterogeneous data. To overcome bottlenecks in multi-target drug discovery, computational algorithms are highly welcomed by scientific community. Machine learning (ML) and especially its subfield deep learning (DL) have seen impressive advances. Techniques developed within these fields are now able to analyze and learn from huge amounts of data in disparate formats. In terms of network pharmacology, ML can improve discovery and decision making from big data. Opportunities to apply ML occur in all stages of network pharmacology research. Examples include screening of biologically active small molecules, target identification, metabolic pathways identification, protein–protein interaction network analysis, hub gene analysis and finding binding affinity between compounds and target proteins. This review summarizes the premier algorithmic concepts of ML in network pharmacology and forecasts future opportunities, potential applications as well as several remaining challenges of implementing ML in network pharmacology. To our knowledge, this study provides the first comprehensive assessment of ML approaches in network pharmacology, and we hope that it encourages additional efforts toward the development and acceptance of network pharmacology in the pharmaceutical industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Network PharmacologyPharmacologyDrug DiscoveryMachine LearningProteinsAlgorithms

Stichwörter der Autor:innen

artificial intelligencedeep learningdrug discoverymachine learningnetwork pharmacology

Substanzen

Proteins

Autor:innen und Institutionen

  • Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.

Zitieren

APA

Noor, F., Asif, M., Ashfaq, U. A., Qasim, M., & Tahir Ul Qamar, M. (2023). Machine learning for synergistic network pharmacology: a comprehensive overview. Briefings in Bioinformatics, 24(3). https://doi.org/10.1093/bib/bbad120

Vancouver

Noor F, Asif M, Ashfaq UA, Qasim M, Tahir Ul Qamar M. Machine learning for synergistic network pharmacology: a comprehensive overview. Briefings in Bioinformatics. 2023;24(3). doi:10.1093/bib/bbad120

BibTeX
@article{Noor2023,
  author = {Noor, Fatima and Asif, Muhammad and Ashfaq, Usman Ali and Qasim, Muhammad and Tahir Ul Qamar, Muhammad},
  title = {Machine learning for synergistic network pharmacology: a comprehensive overview},
  journal = {Briefings in Bioinformatics},
  year = {2023},
  volume = {24},
  number = {3},
  doi = {10.1093/bib/bbad120}
}
Kostenlos starten →